2024. The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team. Voprosy onkologii. 70, 3 (Jul. 2024), 541–549. DOI:https://doi.org/10.37469/0507-3758-2024-70-3-541-549.